FDA-cleared profile

uMI Panorama

Shanghai United Imaging Healthcare Co.,Ltd. · PET/SPECT/Nuclear Medicine · FDA-cleared (510(k))

Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation. K241585 adds reconstruction, respiratory-motion, CT-less attenuation-correction, quantitative-normalization, quality-control, and AI-expanded-field-of-view functions.

Clinical role
Supports acquisition, reconstruction, display, post-processing, quantitative review, and PET/CT registration and fusion. Added functions include AIIR, HYPER Iterative, uExcel DPR, registration-based motion correction, uKinetics, AI-expanded CT field of view, motion management, CT-less attenuation correction, retrospective respiratory gating, uExcel Unity SUV normalization, and radioactive-free uExcel iQC.
Images and patients
PET/SPECT/Nuclear Medicine · Multi-region
Key limitation
Keep in mind: This system is intended to be operated by qualified healthcare professionals. This CT system can be used for low dose CT lung cancer screening for the early detection of lung nodules that may represent cancer. The screening must be performed within the established inclusion criteria of programs / protocols that have been approved and published by either a governmental body or professional medical society.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation. K241585 adds reconstruction, respiratory-motion, CT-less attenuation-correction, quantitative-normalization, quality-control, and AI-expanded-field-of-view functions.
  • Which images or clinical context are in scope?Modality: PET/SPECT/Nuclear Medicine Anatomy or clinical context: Multi-region Input: PET and CT images. The reconstructed PET AC images will be registered to user-selected CT images, and Retrospective Respiratory-gated Scan utilizes respiratory signal to visualize respiratory motion during scan.
  • Who uses it?Intended users: Qualified healthcare professionals.
  • What does the software produce?Output: Quantitative distribution information of PET radiopharmaceuticals within the patient body; diagnostic tomographic anatomical information and photon attenuation information from CT; accurate registration and fusion of PET and CT images; PET AC images generated without CT images and registered to user-selected CT images; phase-based or amplitude-based respiratory-gated reconstructions; accurate SUV normalization; and an automatic QC solution for the PET system.
  • What is its most important limitation?Key limitation: This system is intended to be operated by qualified healthcare professionals. This CT system can be used for low dose CT lung cancer screening for the early detection of lung nodules that may represent cancer. The screening must be performed within the established inclusion criteria of programs / protocols that have been approved and published by either a governmental body or professional medical society.

Clinical takeaway. Clinical role: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation. K241585 adds reconstruction, respiratory-motion, CT-less attenuation-correction, quantitative-normalization, quality-control, and AI-expanded-field-of-view functions.

Evidence takeaway. Evidence from the reviewed source record: Manufacturer-sponsored bench, algorithm, and image review supported the added software functions. The most detailed clinical evaluation was a 13-patient AIEFOV study with a separate test set and two blinded expert readers; it establishes feature-level image performance, not improved clinical outcomes.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation. K241585 adds reconstruction, respiratory-motion, CT-less attenuation-correction, quantitative-normalization, quality-control, and AI-expanded-field-of-view functions.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Workflow role
Supports acquisition, reconstruction, display, post-processing, quantitative review, and PET/CT registration and fusion. Added functions include AIIR, HYPER Iterative, uExcel DPR, registration-based motion correction, uKinetics, AI-expanded CT field of view, motion management, CT-less attenuation correction, retrospective respiratory gating, uExcel Unity SUV normalization, and radioactive-free uExcel iQC.
  • Exact FDA submission
  • Checked 2026-09-02
Required input
PET and CT images. The reconstructed PET AC images will be registered to user-selected CT images, and Retrospective Respiratory-gated Scan utilizes respiratory signal to visualize respiratory motion during scan.
  • Exact FDA submission
  • Checked 2026-09-19

These are the packet's stated PET/CT, user-selected CT, and respiratory-signal inputs; PET coincidence and CT transmission data are not stated in the packet.

Output and clinician action
Quantitative distribution information of PET radiopharmaceuticals within the patient body; diagnostic tomographic anatomical information and photon attenuation information from CT; accurate registration and fusion of PET and CT images; PET AC images generated without CT images and registered to user-selected CT images; phase-based or amplitude-based respiratory-gated reconstructions; accurate SUV normalization; and an automatic QC solution for the PET system.
  • Exact FDA submission
  • Checked 2026-09-19

The packet directly states these PET, CT, fusion, CT-less AC, respiratory-gated, SUV-normalization, and automatic-QC outputs; it does not state the dossier's contemporaneous-CT wording.

Care setting
Professional healthcare facilities performing diagnostic PET/CT and CT imaging.
  • Exact FDA submission
  • Checked 2026-09-02
Intended users
Qualified healthcare professionals.
  • Exact FDA submission
  • Checked 2026-09-19

The indications statement names qualified healthcare professionals and does not add the dossier's acquisition and interpretation role wording.

Limitations
This system is intended to be operated by qualified healthcare professionals. This CT system can be used for low dose CT lung cancer screening for the early detection of lung nodules that may represent cancer. The screening must be performed within the established inclusion criteria of programs / protocols that have been approved and published by either a governmental body or professional medical society.
  • Exact FDA submission
  • Checked 2026-09-19

The replacement preserves the packet's operator and screening boundaries and removes the dossier's unsupported generalization about clinical outcomes and the AIEFOV population.

Evidence summary
Manufacturer-sponsored bench, algorithm, and image review supported the added software functions. The most detailed clinical evaluation was a 13-patient AIEFOV study with a separate test set and two blinded expert readers; it establishes feature-level image performance, not improved clinical outcomes.
  • Exact FDA submission
  • Checked 2026-09-02

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Manufacturer-sponsored bench, algorithm, and image review supported the added software functions. The most detailed clinical evaluation was a 13-patient AIEFOV study with a separate test set and two blinded expert readers; it establishes feature-level image performance, not improved clinical outcomes.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-02
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K241585 added-function verification and clinical-image review

  • DesignManufacturer algorithm, bench, image-performance, and software verification and validation with sample clinical-image review by U.S. board-certified radiologists
  • PopulationuMI Panorama GS software functions including AIIR, HYPER Iterative, uExcel DPR, motion correction, AIEFOV, motion management, CT-less attenuation correction, retrospective respiratory gating, uExcel Unity, and uExcel iQC; the general clinical-image sample size was not reported
  • Scopeexact submission
  • Tested versionuMI Panorama GS software functions cleared in K241585
  • IndependenceSponsor or vendor study

K241585

The FDA summary reports diagnostic sufficiency for reviewed sample images but no clinical outcomes endpoint or independent sponsor.

K241585 AIEFOV clinical evaluation

  • DesignManufacturer-sponsored clinical image evaluation using a test set separated from training and blind review by two U.S. board-qualified clinical experts
  • Population9,303 images from 13 patients representing different CT truncation situations; the training set contained 506,476 manually quality-controlled images
  • Scopeexact submission
  • Tested versionAIEFOV on uMI Panorama GS cleared in K241585
  • Samplen=13
  • IndependenceSponsor or vendor study

K241585

Readers assessed artifacts, tissue homogeneity, and PET diagnostic confidence. FDA reports improved CT-value and SUV accuracy when anatomy exceeded the CT scan field of view and consistent results when it did not; numerical effect sizes were not reported.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: PET and CT images. The reconstructed PET AC images will be registered to user-selected CT images, and Retrospective Respiratory-gated Scan utilizes respiratory signal to visualize respiratory motion during scan.

    Scope: Exact FDA submission. These are the packet's stated PET/CT, user-selected CT, and respiratory-signal inputs; PET coincidence and CT transmission data are not stated in the packet.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K241585: uMI Panorama

  2. Routing

    Source context, not route validation: The scanner control and reconstruction environment provides patient and data management, networking, image display and post-processing, and DICOM-standard image exchange.

    Scope: Exact FDA submission. Confirm DICOM services, PACS and RIS connectivity, CT selection and registration workflows, respiratory-signal interfaces, and quantitative-image preservation for the installed build.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-02 · FDA K241585: uMI Panorama

  3. AI processing

    Source context, not route validation: On-premises uMI Panorama GS PET/CT scanner with a 760 mm bore, 148 cm PET axial field of view, 504 PET detector rings, integrated uCT ATLAS Astound CT subsystem, and table rated to 250 kg.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-02 · FDA K241585: uMI Panorama

  4. Returned objects

    Source context, not route validation: Quantitative distribution information of PET radiopharmaceuticals within the patient body; diagnostic tomographic anatomical information and photon attenuation information from CT; accurate registration and fusion of PET and CT images; PET AC images generated without CT images and registered to user-selected CT images; phase-based or amplitude-based respiratory-gated reconstructions; accurate SUV normalization; and an automatic QC solution for the PET system.

    Scope: Exact FDA submission. The packet directly states these PET, CT, fusion, CT-less AC, respiratory-gated, SUV-normalization, and automatic-QC outputs; it does not state the dossier's contemporaneous-CT wording.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K241585: uMI Panorama

  5. Viewer/worklist/report

    Unresolved route: Quantitative distribution information of PET radiopharmaceuticals within the patient body; diagnostic tomographic anatomical information and photon attenuation information from CT; accurate registration and fusion of PET and CT images; PET AC images generated without CT images and registered to user-selected CT images; phase-based or amplitude-based respiratory-gated reconstructions; accurate SUV normalization; and an automatic QC solution for the PET system.

    Scope: Exact FDA submission. The packet directly states these PET, CT, fusion, CT-less AC, respiratory-gated, SUV-normalization, and automatic-QC outputs; it does not state the dossier's contemporaneous-CT wording.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K241585: uMI Panorama

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
On-premises uMI Panorama GS PET/CT scanner with a 760 mm bore, 148 cm PET axial field of view, 504 PET detector rings, integrated uCT ATLAS Astound CT subsystem, and table rated to 250 kg.
  • Exact FDA submission
  • Checked 2026-09-02
Integration
The scanner control and reconstruction environment provides patient and data management, networking, image display and post-processing, and DICOM-standard image exchange.
  • Exact FDA submission
  • Checked 2026-09-02

Confirm DICOM services, PACS and RIS connectivity, CT selection and registration workflows, respiratory-signal interfaces, and quantitative-image preservation for the installed build.

Security
United Imaging Healthcare's cybersecurity page lists a secure development lifecycle and controls: firewall, encrypted connections, OS hardening, antivirus, patches, authentication, audit log, disk and transmission encryption. Company-level, not release-specific.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation; exact-release scope is not established.

Reconstruction and quantitative workflow

Added AIIR, HYPER Iterative, uExcel DPR, uKinetics, and uExcel Unity functions support image reconstruction, dynamic analysis, and SUV normalization.

exact submission · checked 2026-09-02

Confirm licensed options, supported radiotracers and protocols, reconstruction times, quantitative harmonization, and local quality-control tolerances.

Attenuation and field-of-view functions

CT-less attenuation correction can generate PET attenuation correction without a contemporaneous CT and register the result to a user-selected CT; AIEFOV uses deep learning to extend truncated CT anatomy for supported workflows.

exact submission · checked 2026-09-02

Define CT selection, registration review, fallback, artifact review, and quantitative acceptance procedures before clinical use.

Motion and quality-control functions

Registration-based motion correction, Motion Management, and retrospective respiratory-gated scanning address PET/CT misalignment and respiratory motion; uExcel iQC provides radioactive-free automatic quality control.

exact submission · checked 2026-09-02

Validate respiratory-signal capture, gating rules, failure detection, QC frequency, escalation, and documentation against the installed configuration.

Current product-family context

United Imaging maintains a current uMI Panorama family page, but its claims may cover different axial-field-of-view configurations or software releases and do not substitute for the exact GS quotation and technical file.

product family · checked 2026-09-02

Map every quoted feature, version, interface, service level, and price to the installed 148 cm GS configuration.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K241585
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
PET/SPECT/Nuclear Medicine
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2024-08-30
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
21Fields reviewed
10Source classes checked
8Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 8 PubMed and 0 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 8 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda device recall, vendor product page, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-10-27 - Exact FDA submission

    No public price or quote for the exact K241585 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "United Imaging uMI Panorama reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K241585: uMI Panorama

    U.S. Food and Drug Administration - Published 2024-08-30 - Accessed 2026-09-19

    Scope: purpose, anatomy, intendedUsers, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  6. uMI Panorama product-family page

    United Imaging Healthcare - Accessed 2026-09-02

    Scope: productFamily, implementationCapabilities, currentCommercialContext

  7. United Imaging Healthcare Cybersecurity

    United Imaging Healthcare - Accessed 2026-10-25

    Scope: security

Research history

  1. K241585 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K232712

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-10-03
FDA-cleared K231572

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation in oncology, cardiology, neurology, inflammation, infection, and other disorders. The CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-07-26
FDA-cleared K223325

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-03-10
FDA-cleared K254001

VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364); VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)

Spectrum Dynamics Medical, Ltd.

Authorized purpose: VERITON CT 300/400 Series combines SPECT and CT for detection, localization, diagnosis, staging, restaging, organ-function assessment, therapy planning, guidance, and monitoring. Optional VERITAS.AI applies locked noise-reduction models to reconstructed SPECT images.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2026-01-13

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history